{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:35:44Z","timestamp":1779885344193,"version":"3.53.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Physiological pancreaticoduodenal uptake of radiolabeled exendin-4 in Brunner glands of the proximal duodenum is the most common pitfall for false interpretation of glucagon-like peptide-1 receptor (GLP-1R) imaging. The aim of this study was to analyze the pancreaticoduodenal uptake in GLP-1R PET\/CT and SPECT\/CT images and to identify additional potential reading pitfalls in patients with suspected insulinoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A post hoc analysis of a prospective study, including 52 consecutive patients, was performed. All patients underwent 1 <jats:sup>68<\/jats:sup>Ga-exendin-4 PET\/CT and 2 <jats:sup>111<\/jats:sup>In-exendin-4 SPECT\/CT scans (4 and 72 hours postinjection) in a randomized crossover order. Three board-certified nuclear medicine physicians read all scans independently. They were unaware of other results. Reference standard was surgery with histopathological confirmation of an insulinoma\/nesidioblastosis and normalization of blood glucose levels after surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>There were no false-positive readings. However, there were a number of false-negative PET\/CT and SPECT\/CT readings, respectively: (1) due to false interpretation of uptake in the pancreaticoduodenal region (falsely interpreted as physiological uptake in Brunner glands instead of an insulinoma in 0.6% vs 9.0%), (2) due to ectopic insulinoma (0% vs 2.6%), (3) due to small insulinoma (1.9% vs 5.1%), (4) due to insulinoma overlap with kidneys (1.9% vs 4.5%), and (5) due to nesidioblastosis (0.6% and 1.9%). Pitfalls were identified in all GLP-1R PET\/CT and SPECT\/CT scans.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Peripancreatic uptake, small size of an insulinoma, insulinoma overlap with kidneys, and presence of nesidioblastosis are potential pitfalls in GLP-1R imaging, which can lead to false reading results.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000003124","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T21:21:33Z","timestamp":1601500893000},"page":"e386-e392","source":"Crossref","is-referenced-by-count":20,"title":["Pitfalls in the Detection of Insulinomas With Glucagon-Like Peptide-1 Receptor Imaging"],"prefix":"10.1097","volume":"45","author":[{"given":"Kwadwo","family":"Antwi","sequence":"first","affiliation":[{"name":"Clinic of Radiology and Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Hepprich","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetology and Metabolism, University Hospital Basel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha A.","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Faculty of Clinical Medicine, University of Basel, Basel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Claude","family":"Reubi","sequence":"additional","affiliation":[{"name":"Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Bern, Bern"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melpomeni","family":"Fani","sequence":"additional","affiliation":[{"name":"Clinic of Radiology and Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Rottenburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel R.","family":"Christ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,6,18]]},"reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S2213-8587(13)70049-4","article-title":"Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study","volume":"1","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1007\/s00259-018-4101-5","article-title":"Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET\/CT, SPECT\/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study","volume":"45","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/jc.2013-3541","article-title":"Detection of metastatic insulinoma by positron emission tomography with [(68)Ga]exendin-4\u2014a case report","volume":"99","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2967\/jnumed.110.085142","article-title":"Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas","volume":"52","year":"2011","journal-title":"J Nucl Med"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1210\/jc.2018-02754","article-title":"68Ga-exendin-4 PET\/CT detects insulinomas in patients with endogenous hyperinsulinemic hypoglycemia in MEN-1","volume":"104","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s12020-015-0633-7","article-title":"Preoperative localization of adult nesidioblastosis using 68Ga-DOTA-exendin-4-PET\/CT","volume":"50","year":"2015","journal-title":"Endocrine"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1056\/NEJMc0802045","article-title":"Glucagon-like peptide 1-receptor scans to localize occult insulinomas","volume":"359","year":"2008","journal-title":"N Engl J Med"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2967\/jnumed.106.038679","article-title":"GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting","volume":"48","year":"2007","journal-title":"J Nucl Med"},{"key":"bib9-20230925","first-page":"1","article-title":"Brunner\u2019s gland hyperplasia in a patient after roux-Y gastric bypass: an important pitfall in GLP-1 receptor imaging","volume":"2020","year":"2020","journal-title":"Case Rep Endocrinol"},{"key":"bib10-20230925","first-page":"259","article-title":"Brunner\u2019s glands: a structural, histochemical and pathological profile","volume":"35","year":"2000","journal-title":"Prog Histochem Cytochem"},{"key":"bib11-20230925","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1210\/jc.2009-1082","article-title":"Glucagon-like peptide-1 receptor imaging for localization of insulinomas","volume":"94","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"bib12-20230925","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/jmri.25709","article-title":"Prospective comparison of biphasic contrast-enhanced CT, volume perfusion CT, and 3 tesla MRI with diffusion-weighted imaging for insulinoma detection","volume":"46","year":"2017","journal-title":"J Magn Reson Imaging"},{"key":"bib13-20230925","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12022-013-9262-y","article-title":"Ectopic duodenal insulinoma: a very rare and challenging tumor type. Description of a case and review of the literature","volume":"24","year":"2013","journal-title":"Endocr Pathol"},{"key":"bib14-20230925","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF02739769","article-title":"Human insulinomas: clinical, cellular, and molecular aspects","volume":"10","year":"1999","journal-title":"Endocr Pathol"},{"key":"bib15-20230925","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/cen.12973","article-title":"Application of Ga(68) -DOTA-exendin-4 PET\/CT to localize an occult insulinoma","volume":"84","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"bib16-20230925","first-page":"2025","article-title":"[Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting","volume":"47","year":"2006","journal-title":"J Nucl Med"},{"key":"bib17-20230925","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1097\/RLU.0000000000002522","article-title":"Volume replacement fluid demarks benign Insulinoma with 68Ga-DOTA-exendin-4 PET\/CT","volume":"44","year":"2019","journal-title":"Clin Nucl Med"},{"key":"bib18-20230925","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1148\/radiology.198.1.8539384","article-title":"Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-d-glucose","volume":"198","year":"1996","journal-title":"Radiology"},{"key":"bib19-20230925","first-page":"432","article-title":"Renal uptake of radiolabeled octreotide in human subjects is efficiently inhibited by succinylated gelatin","volume":"47","year":"2006","journal-title":"J Nucl Med"},{"key":"bib20-20230925","first-page":"528","article-title":"Gelatin-based plasma expander effectively reduces renal uptake of 111In-octreotide in mice and rats","volume":"47","year":"2006","journal-title":"J Nucl Med"},{"key":"bib21-20230925","first-page":"812","article-title":"Succinylated gelatin improves the theranostic potential of radiolabeled exendin-4 in insulinoma patients","volume":"60","year":"2018","journal-title":"J Nucl Med"},{"key":"bib22-20230925","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ejim.2004.06.012","article-title":"Nesidioblastosis associated with hyperinsulinemic hypoglycemia in adults: review of the literature","volume":"15","year":"2004","journal-title":"Eur J Intern Med"},{"key":"bib23-20230925","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/01.pas.0000151617.14598.ae","article-title":"Persistent hyperinsulinemic hypoglycemia in 15 adults with diffuse nesidioblastosis: diagnostic criteria, incidence, and characterization of beta-cell changes","volume":"29","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"bib24-20230925","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00259-012-2299-1","article-title":"Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC-99mTc\/EDDA)NH2]-exendin-4 for the detection of insulinoma","volume":"40","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib25-20230925","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2967\/jnumed.119.228627","article-title":"PET-based dosimetry of 68Ga-NODAGA-exendin-4, a tracer for \u03b2-cell imaging","volume":"61","year":"2020","journal-title":"J Nucl Med"},{"key":"bib26-20230925","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.2967\/jnumed.110.074914","article-title":"Exendin-4\u2013based radiopharmaceuticals for glucagonlike peptide-1 receptor PET\/CT and SPECT\/CT","volume":"51","year":"2010","journal-title":"J Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T06:08:40Z","timestamp":1695622120000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,18]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003124","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,18]]}}}